AgeX Therapeutics' Secondary Market Round

AgeX Therapeutics raised a round of funding on August 02, 2018. Investors include Juvenescence.

AgeX Therapeutics develops BioTime technology relating to cell immortality and regenerative biology by developing products for the treatment of aging and age-related diseases.…

Articles about AgeX Therapeutics' Secondary Market Round: